[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![WallStSai Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::90807052.png) S A I ™️ [@WallStSai](/creator/twitter/WallStSai) on x 7058 followers
Created: 2025-07-11 13:18:20 UTC

$NVO Results from a phase 1b/2a randomised controlled study: ‘Amycretin’, a novel unimolecular GLP-1 and amylin receptor agonist administered subcutaneously

“A large number of participants withdrew from the study, with a high proportion of discontinuations occurring due to reasons unrelated to treatment-emergent adverse events”

Source:

$LLY $VKTX #GLP1 #weightloss


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1943661135447654459/c:line.svg)

**Related Topics**
[$lly](/topic/$lly)
[events](/topic/events)
[$nvo](/topic/$nvo)
[stocks healthcare](/topic/stocks-healthcare)
[eli lilly](/topic/eli-lilly)
[$vktx](/topic/$vktx)

[Post Link](https://x.com/WallStSai/status/1943661135447654459)